BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30605980)

  • 21. Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer.
    Hao TB; Shi W; Shen XJ; Qi J; Wu XH; Wu Y; Tang YY; Ju SQ
    Br J Cancer; 2014 Oct; 111(8):1482-9. PubMed ID: 25157833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-free circulating ALU repeats in serum have a prognostic value for colorectal cancer patients.
    Anzinger I; Nagel D; De Toni EN; Ofner A; Philipp AB; Holdt LM; Teupser D; Kolligs FT; Herbst A
    Cancer Biomark; 2023; 37(4):237-248. PubMed ID: 37302022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
    Ni LF; Liu XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
    Chen J; Chen M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1048-1053. PubMed ID: 30523223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus).
    Lukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Siewko M; Szmitkowski M
    J Clin Lab Anal; 2012 Feb; 26(2):73-81. PubMed ID: 22467322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The expressions and diagnostic values of miR-18a and miR-21 in esophageal cancer].
    Yao LH; Wang GR; Cai Y; Ma Q; Wang DS; Xu L; Guo XL
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):107-111. PubMed ID: 30862139
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus.
    Kanda M; Koike M; Shimizu D; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Omae K; Yamada S; Nakayama G; Kodera Y
    Ann Surg Oncol; 2020 Apr; 27(4):1233-1240. PubMed ID: 31650302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
    Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
    Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients.
    Kosugi S; Nishimaki T; Kanda T; Nakagawa S; Ohashi M; Hatakeyama K
    World J Surg; 2004 Jul; 28(7):680-5. PubMed ID: 15383868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
    Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients.
    Groblewska M; Mroczko B; Kozlowski M; Niklinski J; Laudanski J; Szmitkowski M
    Folia Histochem Cytobiol; 2012; 50(4):590-8. PubMed ID: 23264224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of using serum YKL-40 and SCCA in combination for the diagnosis of patients with esophageal squamous cell carcinoma.
    Zheng X; Xing S; Liu XM; Liu W; Liu D; Chi PD; Chen H; Dai SQ; Zhong Q; Zeng MS; Liu WL
    BMC Cancer; 2014 Jul; 14():490. PubMed ID: 25001061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating cell-free DNA in serum as a biomarker of colorectal cancer.
    da Silva Filho BF; Gurgel AP; Neto MÁ; de Azevedo DA; de Freitas AC; Silva Neto Jda C; Silva LA
    J Clin Pathol; 2013 Sep; 66(9):775-8. PubMed ID: 23833048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma DNA Integrity as a Prognostic Biomarker for Colorectal Cancer Chemotherapy.
    Zhu F; Ma J; Ru D; Wu N; Zhang Y; Li H; Liu X; Li J; Zhang H; Xu Y; Zhao J; Tang H; Wang Y; Fu W
    J Oncol; 2021; 2021():5569783. PubMed ID: 34135960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
    Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK
    Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of serum CYFRA 21-1 concentrations in patients with esophageal cancer.
    Brockmann JG; St Nottberg H; Glodny B; Sprakel B; Senninger N
    Anticancer Res; 2000; 20(6D):4899-904. PubMed ID: 11332443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.
    Rapado-González Ó; López-Cedrún JL; Lago-Lestón RM; Abalo A; Rubin-Roger G; Salgado-Barreira Á; López-López R; Muinelo-Romay L; Suárez-Cunqueiro MM
    J Oral Pathol Med; 2022 May; 51(5):429-435. PubMed ID: 35416334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer.
    Ren S; Zeng G; Yi Y; Liu L; Tu H; Chai T; Hu L
    Heliyon; 2023 Oct; 9(10):e20851. PubMed ID: 37860559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients.
    Wu J; Tang W; Huang L; Hou N; Wu J; Cheng X; Ma D; Qian P; Shen Q; Guo W; Peng W; Liu Y; Jiang C; Feng J
    Clin Biochem; 2019 Jan; 63():59-65. PubMed ID: 30292543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.